ASS1 (Argininosuccinate synthase) variants and mutations
ASS1 (also known as Argininosuccinate synthase) is a human protein-coding gene encoding an argininosuccinate synthase protein. It catalyzes formation of argininosuccinate from citrulline and aspartate in the urea cycle, enabling nitrogen disposal and arginine synthesis. Biallelic loss-of-function variants cause citrullinemia type I, which can lead to severe hyperammonemia. This analysis covers 786 ASS1 variants and mutations. Of these, 68% have computational variant effect predictions. Disease context includes citrullinemia type I, citrullinemia, and hereditary disease. Example ASS1 variants include M1I, M1V, and S2T.
Variant analysis overview
- Gene: ASS1
- Protein: Argininosuccinate synthase
- UniProt accession: P00966
- Organism: Homo sapiens
- Variants analyzed: 786
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 612 unspecified-consequence records; 14 frameshift variants; 67 missense variants; 78 synonymous variants; 5 stop-gained variants; 1 in-frame insertions; 1 in-frame deletions; 6 splice-region variants; 2 substitution
- Prediction scores: 531 variants have prediction scores (68% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: citrullinemia type I, citrullinemia, hereditary disease, acute neonatal citrullinemia type I, Intellectual disability, adult-onset citrullinemia type I, citrullinemia type II, disturbances of sensation of smell and taste, autoimmune disorder of central nervous system, alcohol drinking, focal epilepsy, muscular disease.
Protein structure and variant hotspots
- Protein features: 14 binding sites; 7 post-translational modification sites.
- PTM context: 19 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable ASS1 variants
Examples include M1I, M1V, S2T, S2*, S3N, S3I, S3G, S3R. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1I (p.Met1Ile), rs1057516960, ClinGen CA16041297, ClinVar RCV000411464, Likely pathogenic, Citrullinemia type I
- M1V (p.Met1Val), rs750780742, ClinGen CA5283121, ClinVar RCV000665063, Likely pathogenic, Citrullinemia type I
- S2T (p.Ser2Thr), 1000Genomes rs200379004, ExAC rs200379004, gnomAD rs200379004, REVEL 0.36, CADD 18.30
- S2* (p.Ser2Ter), gnomAD 9-130452232-TCC-T, CADD 32.00
- S3N (p.Ser3Asn), rs1845344324, ClinGen CA375223469, ClinVar RCV001325018, Ensembl rs1845344324, Uncertain significance, Citrullinemia
- S3I (p.Ser3Ile), gnomAD 9-130452235-AGCAA, CADD 32.00
- S3G (p.Ser3Gly), gnomAD 9-130452235-A-G, REVEL 0.35, CADD 14.30
- S3R (p.Ser3Arg), gnomAD 9-130452237-C-G, REVEL 0.37, CADD 23.30
- G5A (p.Gly5Ala), rs201700775, ClinGen CA312354, ClinVar RCV001166546, ClinVar RCV002516962, REVEL 0.49, CADD 23.90, Uncertain significance, Inborn genetic diseases; Citrullinemia; Citrullinemia type I
- G5V (p.Gly5Val), ExAC rs201700775, TOPMed rs201700775, gnomAD rs201700775, REVEL 0.71, CADD 24.90, Uncertain significance
- S6A (p.Ser6Ala), rs757913342, ClinGen CA5283124, ClinVar RCV002595194, ExAC rs757913342, REVEL 0.37, CADD 23.00, Uncertain significance, Citrullinemia
- S6F (p.Ser6Phe), NCI-TCGA Cosmic COSV6169, cosmic curated COSV61690, Variant assessed as somatic; moderate impact.
- S6P (p.Ser6Pro), ExAC rs757913342, TOPMed rs757913342, gnomAD rs757913342, REVEL 0.50, CADD 23.80, Uncertain significance
- S6S (p.Ser6Ser), rs555717331, gnomAD 9-130452246-C-T, CADD 8.22
- V7M (p.Val7Met), rs149938546, ClinGen CA5283127, ClinVar RCV000706172, ClinVar RCV001553607, REVEL 0.85, CADD 24.70, Conflicting interpretations, not provided; Citrullinemia type I; Citrullinemia
- V8A (p.Val8Ala), TOPMed rs1845344828
- V8F (p.Val8Phe), Ensembl rs1845344767, REVEL 0.98, CADD 32.00
- L9V (p.Leu9Val), ESP rs144999474, ExAC rs144999474
- L9Q (p.Leu9Gln), gnomAD 9-130452254-T-A, REVEL 0.97, CADD 29.10
- L9L (p.Leu9Leu), gnomAD 9-130452255-G-A, CADD 13.60
- A10P (p.Ala10Pro), rs1845345016, ClinGen CA375223506, ClinVar RCV001044877, TOPMed rs1845345016, REVEL 0.99, CADD 32.00, Uncertain significance, Citrullinemia
- A10D (p.Ala10Asp), gnomAD 9-130452257-C-A, REVEL 0.98, CADD 26.90
- Y11* (p.Tyr11Ter), gnomAD 9-130452261-C-G, CADD 37.00
- Y11Y (p.Tyr11Tyr), rs574820010, gnomAD 9-130452261-C-T, CADD 11.10
- S12G (p.Ser12Gly), gnomAD rs1283372037, REVEL 0.97, CADD 24.50, Uncertain significance, not specified
- G13G (p.Gly13Gly), rs769672308, gnomAD 9-130452267-C-A, CADD 1.61
- G14D (p.Gly14Asp), Ensembl rs1845345374
- G14S (p.Gly14Ser), rs121908636, ClinGen CA253829, cosmic curated COSV61689, ClinVar RCV000006696, REVEL 0.97, CADD 29.30, Pathogenic/Likely pathogenic, Citrullinemia; not provided; Citrullinemia type I
- p.Gly14dup, gnomAD 9-130452262-A-AGT, CADD 21.90
- G14G (p.Gly14Gly), rs1845345426, gnomAD 9-130452270-C-A, CADD 12.10
- L15V (p.Leu15Val), TOPMed rs1845345480, gnomAD rs1845345480, REVEL 0.95, CADD 25.20
- L15W (p.Leu15Trp), gnomAD 9-130452269-GC-G, CADD 25.40
- L15P (p.Leu15Pro), gnomAD 9-130452272-T-C, REVEL 0.98, CADD 32.00
- D16G (p.Asp16Gly), Ensembl rs1588471179, Uncertain significance, Citrullinemia type I
- D16H (p.Asp16His), Ensembl rs1845345553, REVEL 0.97, CADD 32.00, Uncertain significance, Citrullinemia type I
- D16Y (p.Asp16Tyr), cosmic curated COSV61689
- D16A (p.Asp16Ala), gnomAD 9-130452275-A-C, REVEL 0.98, CADD 31.00
- T17A (p.Thr17Ala), TOPMed rs1845345661, gnomAD rs1845345661, REVEL 0.97, CADD 27.10
- T17N (p.Thr17Asn), gnomAD 9-130452278-C-A, REVEL 0.92, CADD 25.30
- T17I (p.Thr17Ile), gnomAD 9-130452278-C-T, REVEL 0.97, CADD 26.10
- T17T (p.Thr17Thr), gnomAD 9-130452279-C-G, CADD 7.49
- S18* (p.Ser18Ter), cosmic curated COSV10943, CADD 37.00
- S18L (p.Ser18Leu), rs121908643, ClinGen CA253836, ClinVar RCV000006703, ClinVar RCV002512847, REVEL 0.98, CADD 28.10, Pathogenic/Likely pathogenic, Citrullinemia; Citrullinemia type I
- S18W (p.Ser18Trp), gnomAD 9-130452281-C-G, REVEL 0.97, CADD 27.60
- S18S (p.Ser18Ser), rs768923973, gnomAD 9-130452282-G-A, CADD 8.46
- C19* (p.Cys19Ter), rs2490515237, ClinGen CA375223569, ClinVar RCV003593586, CADD 36.00, Pathogenic, in CTLN1
- C19R (p.Cys19Arg), UniProt VAR 015891, Pathogenic, in CTLN1
- I20L (p.Ile20Leu), gnomAD 9-130452286-A-C, REVEL 0.86, CADD 27.60
- I20I (p.Ile20Ile), gnomAD 9-130452288-C-A, CADD 12.70
- L21F (p.Leu21Phe), Ensembl rs1845345943, REVEL 0.90, CADD 26.00
- L21L (p.Leu21Leu), rs774476997, gnomAD 9-130452291-C-T, CADD 8.87
- V22G (p.Val22Gly), rs912037125, ClinGen CA200603554, cosmic curated COSV61688, ClinVar RCV003067066, REVEL 0.88, CADD 24.80, Uncertain significance, Citrullinemia; Inborn genetic diseases
- V22L (p.Val22Leu), rs762279472, NCI-TCGA Cosmic COSV6168, cosmic curated COSV61688, ExAC rs762279472, REVEL 0.45, CADD 21.90, Uncertain significance, Inborn genetic diseases
- V22M (p.Val22Met), ExAC rs762279472, TOPMed rs762279472, gnomAD rs762279472, REVEL 0.74, CADD 24.30, Uncertain significance, Inborn genetic diseases
- V22A (p.Val22Ala), gnomAD 9-130452282-G-GTG, CADD 29.00
- V22V (p.Val22Val), rs148653590, gnomAD 9-130452294-G-A, CADD 12.20
- W23* (p.Trp23Ter), rs1175810875, ClinGen CA375223594, ClinVar RCV003463553, TOPMed rs1175810875, Likely pathogenic
- W23C (p.Trp23Cys), TOPMed rs1175810875, Likely pathogenic
- W23L (p.Trp23Leu), NCI-TCGA Cosmic COSV1007, cosmic curated COSV10075, Variant assessed as somatic; moderate impact.
- L24R (p.Leu24Arg), NCI-TCGA TCGA novel, REVEL 0.99, CADD 31.00, Variant assessed as somatic; moderate impact.
- K25K (p.Lys25Lys), rs1845346515, gnomAD 9-130452303-G-A, CADD 12.80
- E26K (p.Glu26Lys), rs766668660, ExAC rs766668660, TOPMed rs766668660, gnomAD rs766668660, REVEL 0.88, CADD 25.80, Variant assessed as somatic; moderate impact.
- Q27K (p.Gln27Lys), 1000Genomes rs543339767, ExAC rs543339767, TOPMed rs543339767, gnomAD rs543339767, REVEL 0.60, CADD 21.70
- Q27* (p.Gln27Ter), gnomAD 9-130452307-C-T, CADD 38.00
- Q27Q (p.Gln27Gln), gnomAD 9-130452309-A-G, CADD 9.94
- G28G (p.Gly28Gly), rs1386337873, gnomAD 9-130452312-C-A, CADD 11.60
- Y29C (p.Tyr29Cys), rs1457270102, ClinGen CA375223632, ClinVar RCV001297859, TOPMed rs1457270102, REVEL 0.87, CADD 31.00, Uncertain significance, Citrullinemia
- Y29H (p.Tyr29His), gnomAD 9-130452313-T-C, REVEL 0.88, CADD 24.70
- Y29Y (p.Tyr29Tyr), gnomAD 9-130452315-T-C, CADD 5.39
- D30N (p.Asp30Asn), cosmic curated COSV61690, ExAC rs758038108, TOPMed rs758038108, gnomAD rs758038108, REVEL 0.71, CADD 24.00
- D30Y (p.Asp30Tyr), ExAC rs758038108, TOPMed rs758038108, gnomAD rs758038108, REVEL 0.93, CADD 32.00
- D30E (p.Asp30Glu), gnomAD 9-130452318-C-A, REVEL 0.56, CADD 1.21
- D30D (p.Asp30Asp), rs371519061, gnomAD 9-130452318-C-T, CADD 7.42
- V31I (p.Val31Ile), ESP rs374444560, ExAC rs374444560, TOPMed rs374444560, gnomAD rs374444560, REVEL 0.69, CADD 24.40, Uncertain significance, Citrullinemia type I
- V31F (p.Val31Phe), gnomAD 9-130452319-G-T, REVEL 0.96, CADD 29.20
- V31V (p.Val31Val), gnomAD 9-130452321-C-T, CADD 14.20
- I32T (p.Ile32Thr), gnomAD rs1313069512, REVEL 0.96, CADD 23.40
- I32V (p.Ile32Val), rs142221856, ClinGen CA200603573, ClinVar RCV002034332, ESP rs142221856, REVEL 0.46, CADD 18.10, Uncertain significance, Citrullinemia
- I32I (p.Ile32Ile), gnomAD 9-130452324-T-A, CADD 6.76
- A33S (p.Ala33Ser), Ensembl rs200254372
- A33A (p.Ala33Ala), rs147842617, gnomAD 9-130452327-C-T, CADD 12.80
- Y34N (p.Tyr34Asn), Ensembl rs1554982006
- Y34del (p.Tyr34del), gnomAD 9-130452328-TATC-, CADD 19.50
- Y34S (p.Tyr34Ser), gnomAD 9-130452329-A-C, REVEL 0.86, CADD 27.20
- Y34C (p.Tyr34Cys), gnomAD 9-130452329-A-G, REVEL 0.76, CADD 24.70
- Y34* (p.Tyr34Ter), gnomAD 9-130452330-T-G, CADD 36.00
- Y34Y (p.Tyr34Tyr), rs1236633346, gnomAD 9-130452330-T-C, CADD 10.30
- L35L (p.Leu35Leu), rs532327473, gnomAD 9-130452331-C-T, CADD 19.40
- A36D (p.Ala36Asp), gnomAD rs1479796639, REVEL 0.96, CADD 28.90
- A36V (p.Ala36Val), NCI-TCGA Cosmic COSV1007, cosmic curated COSV10075, Variant assessed as somatic; moderate impact.
- A36T (p.Ala36Thr), gnomAD 9-130454305-G-A, REVEL 0.93, CADD 32.00
- A36G (p.Ala36Gly), gnomAD 9-130454306-C-G, REVEL 0.88, CADD 27.60
- N37D (p.Asn37Asp), cosmic curated COSV10466
- N37K (p.Asn37Lys), Ensembl rs1845388217, REVEL 0.64, CADD 21.70
- N37S (p.Asn37Ser), TOPMed rs1412223944, gnomAD rs1412223944
- N37T (p.Asn37Thr), TOPMed rs1412223944, gnomAD rs1412223944, REVEL 0.81, CADD 23.80, Uncertain significance, Inborn genetic diseases
- I38T (p.Ile38Thr), TOPMed rs1845388353, REVEL 0.81, CADD 24.20
- I38V (p.Ile38Val), gnomAD rs1176198275, REVEL 0.35, CADD 14.80
- I38F (p.Ile38Phe), gnomAD 9-130454311-A-T, REVEL 0.89, CADD 23.30
- I38I (p.Ile38Ile), gnomAD 9-130454313-T-C, CADD 10.30
- G39R (p.Gly39Arg), rs2131869276, ClinGen CA375223705, ClinVar RCV001559206, ClinVar RCV001751801, REVEL 0.97, CADD 29.20, Conflicting interpretations, Citrullinemia type I; Citrullinemia; not provided
- G39S (p.Gly39Ser), rs2131869276, ClinGen CA375223704, ClinVar RCV003369883, Uncertain significance, Inborn genetic diseases
- G39C (p.Gly39Cys), gnomAD 9-130454314-G-T, REVEL 0.97, CADD 32.00
- G39G (p.Gly39Gly), rs1378899995, gnomAD 9-130454316-C-T, CADD 13.30
- Q40H (p.Gln40His), ExAC rs751131164, cosmic curated COSV10819
- Q40L (p.Gln40Leu), rs2131869283, ClinGen CA375223715, ClinVar RCV003464667, Ensembl rs2131869283, Likely pathogenic, Citrullinemia type I
- Q40* (p.Gln40Ter), gnomAD 9-130454317-C-T, CADD 41.00
- K41* (p.Lys41Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- E42K (p.Glu42Lys), rs1460136199, ClinGen CA375223725, NCI-TCGA Cosmic COSV1007, cosmic curated COSV10075, Uncertain significance, Inborn genetic diseases
- E42G (p.Glu42Gly), gnomAD 9-130454324-A-G, REVEL 0.89, CADD 32.00
- D43H (p.Asp43His), gnomAD rs1167026676, REVEL 0.93, CADD 28.60
- D43N (p.Asp43Asn), gnomAD 9-130454326-G-A, REVEL 0.67, CADD 23.50
- F44L (p.Phe44Leu), rs761408245, ClinGen CA375223747, ClinVar RCV004422921, Uncertain significance, Inborn genetic diseases
- F44S (p.Phe44Ser), gnomAD 9-130454330-T-C, REVEL 0.86, CADD 25.50
- F44F (p.Phe44Phe), rs761408245, gnomAD 9-130454331-C-T, CADD 3.11
- E45D (p.Glu45Asp), cosmic curated COSV61689
- E45K (p.Glu45Lys), rs766880501, ClinGen CA5283162, ClinVar RCV003062803, ClinVar RCV004526960, REVEL 0.45, CADD 23.20, Uncertain significance, Citrullinemia; not specified
- E45E (p.Glu45Glu), gnomAD 9-130454334-G-A, CADD 9.10
- E46E (p.Glu46Glu), gnomAD 9-130454337-A-G, CADD 10.10
- A47D (p.Ala47Asp), TOPMed rs1301161301, gnomAD rs1301161301, REVEL 0.90, CADD 22.70, Uncertain significance
- A47V (p.Ala47Val), rs1301161301, ClinGen CA375223769, ClinVar RCV001992848, ClinVar RCV003401949, REVEL 0.69, CADD 22.50, Uncertain significance, Citrullinemia; not specified; Citrullinemia type I
- R48G (p.Arg48Gly), rs374695792, ClinGen CA5283163, ClinVar RCV001247594, ClinVar RCV002241806, REVEL 0.75, CADD 26.60, Uncertain significance, Citrullinemia; Inborn genetic diseases
- R48R (p.Arg48Arg), rs756107583, gnomAD 9-130454343-G-A, CADD 13.90
- K49G (p.Lys49Gly), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- K50T (p.Lys50Thr), gnomAD 9-130454348-A-C, REVEL 0.94, CADD 26.90
- A51T (p.Ala51Thr), rs142350255, ClinGen CA5283165, ClinVar RCV001351742, ClinVar RCV001831176, REVEL 0.94, CADD 28.30, Uncertain significance, Citrullinemia
- A51S (p.Ala51Ser), gnomAD 9-130454350-G-T, REVEL 0.89, CADD 23.20
- A51A (p.Ala51Ala), rs1303466623, gnomAD 9-130454352-A-G, CADD 5.24
- L54F (p.Leu54Phe), Ensembl rs1564902078, REVEL 0.58, CADD 22.50, Uncertain significance
- L54V (p.Leu54Val), rs1564902078, ClinGen CA375223842, ClinVar RCV000701082, ClinVar RCV002233353, Uncertain significance, Citrullinemia
- L54H (p.Leu54His), gnomAD 9-130454360-T-A, REVEL 0.89, CADD 27.30
- L54P (p.Leu54Pro), gnomAD 9-130454360-T-C, REVEL 0.88, CADD 24.50
- G55E (p.Gly55Glu), gnomAD 9-130454363-G-A, REVEL 0.94, CADD 26.70
- G55G (p.Gly55Gly), rs146333243, gnomAD 9-130454364-G-A, CADD 7.05
- A56D (p.Ala56Asp), rs2131869336, ClinGen CA375223867, ClinVar RCV002019823, Ensembl rs2131869336, Uncertain significance, Citrullinemia
- A56T (p.Ala56Thr), rs773150312, ClinGen CA5283167, ClinVar RCV002840490, ExAC rs773150312, REVEL 0.86, CADD 26.10, Uncertain significance, Inborn genetic diseases
- A56V (p.Ala56Val), gnomAD 9-130454366-C-T, REVEL 0.82, CADD 26.00
- K57E (p.Lys57Glu), ExAC rs779222693, gnomAD rs779222693, REVEL 0.58, CADD 20.30
- K57R (p.Lys57Arg), gnomAD 9-130454369-A-G, REVEL 0.48, CADD 19.30
- K58R (p.Lys58Arg), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- K58E (p.Lys58Glu), gnomAD 9-130454371-A-G, REVEL 0.62, CADD 23.00
- K58K (p.Lys58Lys), rs1344685348, gnomAD 9-130454373-G-A, CADD 24.50
- V59L (p.Val59Leu), cosmic curated COSV61690
- V59M (p.Val59Met), gnomAD rs1390986372, REVEL 0.72, CADD 25.80
- V59V (p.Val59Val), rs781678927, gnomAD 9-130458403-G-A, CADD 11.80
- F60C (p.Phe60Cys), ExAC rs746316364, gnomAD rs746316364, REVEL 0.86, CADD 25.90
- F60L (p.Phe60Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- F60I (p.Phe60Ile), gnomAD 9-130458404-T-A, REVEL 0.55, CADD 21.80
- F60F (p.Phe60Phe), rs1478353987, gnomAD 9-130458406-C-T, CADD 12.40
- I61T (p.Ile61Thr), rs769314825, ClinGen CA5283194, ClinVar RCV002886540, ExAC rs769314825, REVEL 0.89, CADD 24.10, Uncertain significance, Citrullinemia
- I61V (p.Ile61Val), TOPMed rs1423131094
- I61I (p.Ile61Ile), rs1036284939, gnomAD 9-130458409-T-C, CADD 4.57
- E62K (p.Glu62Lys), TOPMed rs1230404130, gnomAD rs1230404130, REVEL 0.70, CADD 23.60
- D63G (p.Asp63Gly), rs1305436274, gnomAD 9-130458413-GAT-G, CADD 33.00
- V64F (p.Val64Phe), NCI-TCGA Cosmic COSV6168, cosmic curated COSV61688, Uncertain significance, in CTLN1
- V64I (p.Val64Ile), rs556297791, ClinGen CA5283195, ClinVar RCV000669936, ClinVar RCV001363462, REVEL 0.21, CADD 17.80, Uncertain significance, Citrullinemia
- V64V (p.Val64Val), gnomAD 9-130458418-C-T, CADD 10.60
- S65N (p.Ser65Asn), cosmic curated COSV10075
- S65G (p.Ser65Gly), gnomAD 9-130458419-A-G, REVEL 0.58, CADD 24.20
- R66K (p.Arg66Lys), Ensembl rs2131873963
- E67* (p.Glu67Ter), rs1257036291, ClinGen CA375224882, ClinVar RCV003761019, Pathogenic
- E67K (p.Glu67Lys), rs1257036291, ClinGen CA375224878, ClinVar RCV003105044, TOPMed rs1257036291, Uncertain significance, Citrullinemia
- E67D (p.Glu67Asp), gnomAD 9-130458427-G-T, REVEL 0.60, CADD 19.20
- F68S (p.Phe68Ser), gnomAD 9-130458429-T-C, REVEL 0.98, CADD 31.00
- V69A (p.Val69Ala), rs771594651, ClinGen CA5283197, ClinVar RCV002221689, ClinVar RCV003475100, REVEL 0.90, CADD 27.10, Conflicting interpretations, not provided; Citrullinemia; Citrullinemia type I
- V69L (p.Val69Leu), gnomAD 9-130458431-G-T, REVEL 0.81, CADD 23.40
- V69V (p.Val69Val), rs2131873972, gnomAD 9-130458433-G-A, CADD 11.90
- E70E (p.Glu70Glu), rs1465915503, gnomAD 9-130458436-G-A, CADD 10.70
- E71G (p.Glu71Gly), gnomAD 9-130458435-A-AG, CADD 32.00
- E71A (p.Glu71Ala), gnomAD 9-130458438-A-C, REVEL 0.85, CADD 24.70
- E71E (p.Glu71Glu), rs373501531, gnomAD 9-130458439-G-A, CADD 10.60
- F72I (p.Phe72Ile), rs1845500156, ClinGen CA375224957, ClinVar RCV003878027, TOPMed rs1845500156, REVEL 0.90, CADD 25.00, Likely pathogenic, Citrullinemia
- F72L (p.Phe72Leu), rs1554982824, ClinGen CA375224971, ClinVar RCV000666531, ClinVar RCV002530687, Conflicting interpretations, Citrullinemia; not provided
- F72Y (p.Phe72Tyr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- W74* (p.Trp74Ter), rs2490531268, ClinGen CA375224998, ClinVar RCV003594754, CADD 39.00, Pathogenic
- P75L (p.Pro75Leu), ExAC rs760286858, TOPMed rs760286858, gnomAD rs760286858, REVEL 0.79, CADD 23.90
- P75P (p.Pro75Pro), rs765933359, gnomAD 9-130458451-G-A, CADD 2.32
- A76S (p.Ala76Ser), gnomAD 9-130458452-G-T, REVEL 0.55, CADD 23.50
- A76V (p.Ala76Val), gnomAD 9-130458453-C-T, REVEL 0.79, CADD 25.60
- A76A (p.Ala76Ala), rs1220196767, gnomAD 9-130458454-C-G, CADD 8.19
Public ASS1 analysis runs
- ASS1 analysis run — ASS1 (786 variants) — completed 2026-08-19